251 related articles for article (PubMed ID: 21303424)
1. Renoprotective efficacy of valsartan in chronic non-diabetic proteinuric nephropathies with renin-angiotensin system gene polymorphisms.
Lee YJ; Jang HR; Kim SG; Chae DW; Do JY; Lee JE; Huh W; Kim DJ; Oh HY; Kim YG
Nephrology (Carlton); 2011 Jul; 16(5):502-10. PubMed ID: 21303424
[TBL] [Abstract][Full Text] [Related]
2. The influence of renin-angiotensin system genotypes on the antiproteinuric response to high doses of olmesartan in non-diabetic proteinuric nephropathies.
Goyache-Goñi B; Aranda-Lara P; Reyes-Engels A; Frutos-Sanz MA; Hernández-Marrero D
Nefrologia; 2013 Nov; 33(6):771-8. PubMed ID: 24241364
[TBL] [Abstract][Full Text] [Related]
3. Low renin-angiotensin system activity gene polymorphism and dysplasia associated with posterior urethral valves.
Peruzzi L; Lombardo F; Amore A; Merlini E; Restagno G; Silvestro L; Papalia T; Coppo R
J Urol; 2005 Aug; 174(2):713-7. PubMed ID: 16006956
[TBL] [Abstract][Full Text] [Related]
4. Antiproteinuric effect of losartan in non-diabetic renal disease is not dependent on ACE insertion/deletion polymorphism.
Park HC; Choi HY; Kim BS; Kang SW; Choi KH; Ha SK; Lee HY; Han DS
Kidney Blood Press Res; 2006; 29(4):216-24. PubMed ID: 16960460
[TBL] [Abstract][Full Text] [Related]
5. Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients.
Böger CA; Götz AK; Krüger B; Hösl M; Schmitz G; Riegger GA; Krämer BK
Eur J Med Res; 2005 Apr; 10(4):161-8. PubMed ID: 15946912
[TBL] [Abstract][Full Text] [Related]
6. Renin-angiotensin system polymorphisms: a risk factor for progression to end-stage renal disease in vesicoureteral reflux patients.
Akman B; Tarhan C; Arat Z; Sezer S; Ozdemir FN
Ren Fail; 2009; 31(3):196-200. PubMed ID: 19288324
[TBL] [Abstract][Full Text] [Related]
7. Strong suppression of the renin-angiotensin system has a renal-protective effect in hypertensive patients: high-dose ARB with ACE inhibitor (Hawaii) study.
Ohishi M; Takeya Y; Tatara Y; Yamamoto K; Onishi M; Maekawa Y; Kamide K; Rakugi H
Hypertens Res; 2010 Nov; 33(11):1150-4. PubMed ID: 20703230
[TBL] [Abstract][Full Text] [Related]
8. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacogenetics of angiotensin system in non diabetic nephropathy].
Coto E; Marín R; Alvarez V; Praga M; Fernández Andrade C; Arias M; Poveda R; Vallés M; Galcerán JM; Luño J; Rivera F; Campistol JM
Nefrologia; 2005; 25(4):381-6. PubMed ID: 16231503
[TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease.
Buraczyńska M; Pijanowski Z; Spasiewicz D; Nowicka T; Sodolski T; Widomska - Czekajska T; Ksiazek A
Kardiol Pol; 2003 Jan; 58(1):1-9. PubMed ID: 14502296
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker.
Zhu S; Liu Y; Wang L; Meng QH
Nephrol Dial Transplant; 2008 Sep; 23(9):2841-6. PubMed ID: 18390891
[TBL] [Abstract][Full Text] [Related]
12. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
[TBL] [Abstract][Full Text] [Related]
13. Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients.
Renke M; Tylicki L; Rutkowski P; Wojnarowski K; Lysiak-Szydlowska W; Rutkowski B
Scand J Urol Nephrol; 2005; 39(6):511-7. PubMed ID: 16303729
[TBL] [Abstract][Full Text] [Related]
14. Enalapril and losartan affect lipid peroxidation in renal transplant recipients with renin-angiotensin system polymorphisms.
Rashtchizadeh N; Aghaeishahsavari M; Argani H; Noroozianavval M; Veisi P; Ghorbanihaghjo A
Clin Biochem; 2007 Feb; 40(3-4):194-200. PubMed ID: 17222813
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease.
Buraczynska M; Ksiazek P; Drop A; Zaluska W; Spasiewicz D; Ksiazek A
Nephrol Dial Transplant; 2006 Apr; 21(4):979-83. PubMed ID: 16384824
[TBL] [Abstract][Full Text] [Related]
16. Genotypic interactions of renin-angiotensin system genes with diabetes type 2 in a Tunisian population.
Mehri S; Koubaa N; Hammami S; Mahjoub S; Chaaba R; Nakbi A; Zouari B; Abid M; Ben Arab S; Baudin B; Hammami M
Life Sci; 2010 Jul; 87(1-2):49-54. PubMed ID: 20580725
[TBL] [Abstract][Full Text] [Related]
17. Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
Esnault VL; Ekhlas A; Nguyen JM; Moranne O
Nephrol Dial Transplant; 2010 Jul; 25(7):2218-24. PubMed ID: 20106824
[TBL] [Abstract][Full Text] [Related]
18. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.
Marre M; Jeunemaitre X; Gallois Y; Rodier M; Chatellier G; Sert C; Dusselier L; Kahal Z; Chaillous L; Halimi S; Muller A; Sackmann H; Bauduceau B; Bled F; Passa P; Alhenc-Gelas F
J Clin Invest; 1997 Apr; 99(7):1585-95. PubMed ID: 9120002
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of RAS inhibitors associated with ACE gene polymorphisms in type 2 diabetic nephropathy.
Seki N; Hashimoto N; Suzuki Y; Yagui K; Saito Y
Diabetes Res Clin Pract; 2006 May; 72(2):135-41. PubMed ID: 16290123
[TBL] [Abstract][Full Text] [Related]
20. Genotypic interactions of renin-angiotensin system genes in myocardial infarction.
Araújo MA; Goulart LR; Cordeiro ER; Gatti RR; Menezes BS; Lourenço C; Silva HD
Int J Cardiol; 2005 Aug; 103(1):27-32. PubMed ID: 16061119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]